Alimera Sciences: Q2 Earnings Snapshot
In this article:
ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Alimera Sciences Inc. (ALIM) on Thursday reported a loss of $10 million in its second quarter.
The Alpharetta, Georgia-based company said it had a loss of $1.32 per share. Losses, adjusted for non-recurring costs, were 44 cents per share.
The eye drug developer posted revenue of $17.5 million in the period.
The company's shares closed at $3.13. A year ago, they were trading at $6.78.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALIM at https://www.zacks.com/ap/ALIM
